|
Q3 FY2026
As of May 31, 2026
|
Q2 FY2026
As of Feb 28, 2026
|
Q1 FY2026
As of Nov 30, 2025
|
Q4 FY2025
As of Aug 31, 2025
|
Q3 FY2025
As of May 31, 2025
|
Q2 FY2025
As of Feb 28, 2025
|
Q1 FY2025
As of Nov 30, 2024
|
Q4 FY2024
As of Aug 31, 2024
|
Q3 FY2024
As of May 31, 2024
|
Q2 FY2024
As of Feb 29, 2024
|
Q1 FY2024
As of Nov 30, 2023
|
Q4 FY2023
As of Aug 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets | ||||||||||||
| Cash | ||||||||||||
| Restricted cash | ||||||||||||
| Trade and other receivables | ||||||||||||
| Financing arrangements | ||||||||||||
| Related Party | ||||||||||||
| Total financing arrangements | ||||||||||||
| Prepaid expenses and deposits | ||||||||||||
| Total current assets | ||||||||||||
| Investment | ||||||||||||
| Digital assets | ||||||||||||
| Right-of-use asset – net | ||||||||||||
| Property and equipment – net | ||||||||||||
| Intangible assets - net | ||||||||||||
| Total Assets | ||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||
| Current liabilities | ||||||||||||
| Loan | ||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||
| Loans payable – related parties | ||||||||||||
| Related Party | ||||||||||||
| Total loans payable – related parties | ||||||||||||
| Deferred revenue | ||||||||||||
| Warrant liability | ||||||||||||
| Derivative liability | ||||||||||||
| Loans from directors | ||||||||||||
| Current portion of lease liability | ||||||||||||
| Total current liabilities | ||||||||||||
| Deferred government incentive | ||||||||||||
| Conversion note payable | ||||||||||||
| Conversion feature liability | ||||||||||||
| Lease liability | ||||||||||||
| Warrant liability | ||||||||||||
| Total liabilities | ||||||||||||
| Shareholders’ Equity | ||||||||||||
| Common shares (*), no par value; unlimited authorized; 25,534,070 issued and outstanding shares as of May 31, 2026 and 1,340,941 as at August 31, 2025. | ||||||||||||
| Common shares to be issued | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated other comprehensive loss | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders’ equity | ||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
